{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:07Z","timestamp":1792631467409,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s10072-019-03935-y","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:01:54Z","timestamp":1558537314000},"page":"1785-1797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Yulei","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-9031","authenticated-orcid":false,"given":"Jiachun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"issue":"2","key":"3935_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52(2):148\u2013159","journal-title":"Am J Med"},{"key":"3935_CR2","unstructured":"Hoffman R, Bezruczko N, Perkins K (2012) An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients. J Appl Meas 13(2):205\u2013216"},{"key":"3935_CR3","unstructured":"Perkins K, Hoffman RW, Bezruczko N (2008) A Rasch analysis for classification of systemic lupus erythematosus and mixed connective tissue disease. J Appl Meas 9(2):136\u2013150"},{"issue":"8","key":"3935_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/art.1780210818","volume":"21","author":"T Weiss","year":"1978","unstructured":"Weiss T, Nelson J, Woolsey R, Zuckner J, Baldassare A (1978) Transverse myelitis in mixed connective tissue disease. Arthritis Rheum 21(8):982\u2013986","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"3935_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00062-015-0401-3","volume":"25","author":"M Nichtwei\u00df","year":"2015","unstructured":"Nichtwei\u00df M, Weidauer S (2015) Differential diagnosis of acute myelopathies: an update. Clin Neuroradiol 25(Suppl 2):183\u2013187","journal-title":"Clin Neuroradiol"},{"issue":"11","key":"3935_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/archderm.1976.01630350011003","volume":"112","author":"W Minkin","year":"1976","unstructured":"Minkin W, Rabhan N (1976) Mixed connective tissue disease. Arch Dermatol 112(11):1535\u20131538","journal-title":"Arch Dermatol"},{"issue":"6","key":"3935_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/ard.2010.143792","volume":"70","author":"R Gunnarsson","year":"2011","unstructured":"Gunnarsson R, Molberg O, Gilboe IM, Gran JT (2011) The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 70(6):1047\u20131051. https:\/\/doi.org\/10.1136\/ard.2010.143792","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3935_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/acr.22872","volume":"68","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL (2016) Epidemiology of mixed connective tissue disease, 1985\u20132014: a population-based study. Arthritis Care Res 68(12):1843\u20131848. https:\/\/doi.org\/10.1002\/acr.22872","journal-title":"Arthritis Care Res"},{"issue":"8","key":"3935_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/acr.23135","volume":"69","author":"E Ferucci","year":"2017","unstructured":"Ferucci E, Johnston J, Gordon C, Helmick C, Lim S (2017) Prevalence of mixed connective tissue disease in a population-based Registry of American Indian\/Alaska Native People in 2007. Arthritis Care Res 69(8):1271\u20131275","journal-title":"Arthritis Care Res"},{"issue":"1","key":"3935_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/tan.12698","volume":"87","author":"A Paradowska-Gorycka","year":"2016","unstructured":"Paradowska-Gorycka A, Stypinska B, Olesinska M, Felis-Giemza A, Manczak M, Czuszynska Z, Zdrojewski Z, Wojciechowicz J, Jurkowska M (2016) Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients. Hla 87(1):13\u201318. https:\/\/doi.org\/10.1111\/tan.12698","journal-title":"Hla"},{"issue":"3","key":"3935_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5114\/reum.2015.53136","volume":"53","author":"A Paradowska-Gorycka","year":"2015","unstructured":"Paradowska-Gorycka A (2015) U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia 53(3):143\u2013151","journal-title":"Reumatologia"},{"issue":"2","key":"3935_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/03009749309095117","volume":"22","author":"R Hameenkorpi","year":"1993","unstructured":"Hameenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Makitalo R, Hakala M (1993) More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol 22(2):63\u201368","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"3935_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/tan.12027","volume":"81","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Inoue H, Komai K, Yamane T, Hashiramoto A, Shiozawa K, Shiozawa S (2013) Mixed connective tissue disease is distinct from systemic lupus erythematosus: study of major histocompatibility complex class I polypeptide-related sequence A and HLA gene polymorphisms. Tissue Antigens 81(1):44\u201345. https:\/\/doi.org\/10.1111\/tan.12027","journal-title":"Tissue Antigens"},{"issue":"1","key":"3935_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.medcli.2017.06.066","volume":"150","author":"J Mart\u00ednez-Barrio","year":"2018","unstructured":"Mart\u00ednez-Barrio J, Valor L, L\u00f3pez-Longo F (2018) Facts and controversies in mixed connective tissue disease. Med Clin (Barc) 150(1):26\u201332","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"3935_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","volume":"38","author":"A Dima","year":"2018","unstructured":"Dima A, Jurcut C, Baicus C (2018) The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int 38(7):1169\u20131178. https:\/\/doi.org\/10.1007\/s00296-018-4059-4","journal-title":"Rheumatol Int"},{"issue":"21","key":"3935_CR16","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/nejm197611182952101","volume":"295","author":"GC Sharp","year":"1976","unstructured":"Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR (1976) Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 295(21):1149\u20131154. https:\/\/doi.org\/10.1056\/nejm197611182952101","journal-title":"N Engl J Med"},{"issue":"10","key":"3935_CR17","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archinte.1977.03630220108028","volume":"137","author":"W Minkin","year":"1977","unstructured":"Minkin W, Rabhan N (1977) Mixed connective tissue disease. Arch Intern Med 137(10):1484","journal-title":"Arch Intern Med"},{"issue":"1","key":"3935_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3899\/jrheum.140047","volume":"42","author":"AM Hoffmann-Vold","year":"2015","unstructured":"Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt \u00d8, Molberg \u00d8 (2015) Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 42(1):60\u201363","journal-title":"J Rheumatol"},{"issue":"2","key":"3935_CR19","first-page":"259","volume":"19","author":"A Doria","year":"1992","unstructured":"Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF (1992) Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 19(2):259\u2013264","journal-title":"J Rheumatol"},{"issue":"12","key":"3935_CR20","first-page":"2055","volume":"23","author":"JM Amigues","year":"1996","unstructured":"Amigues JM, Cantagrel A, Abbal M, Mazieres B (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 23(12):2055\u20132062","journal-title":"J Rheumatol"},{"issue":"4","key":"3935_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","volume":"41","author":"S Cappelli","year":"2012","unstructured":"Cappelli S, Bellando Randone S, Martinovic D, Tamas MM, Pasalic K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radic M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirjak L, Damjanov N, Rednic S, Matucci Cerinic M (2012) \"To be or not to be,\" ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41(4):589\u2013598. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.07.010","journal-title":"Semin Arthritis Rheum"},{"key":"3935_CR22","doi-asserted-by":"crossref","unstructured":"Fl\u00e5m S, Gunnarsson R, Garen T, Lie B, Molberg \u00d8 (2015) The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatology 54(3):528\u2013535","DOI":"10.1093\/rheumatology\/keu310"},{"issue":"2","key":"3935_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0961203309345782","volume":"19","author":"LV Lage","year":"2010","unstructured":"Lage LV, Caleiro MT, Carvalho JF (2010) Proposed disease activity criteria for mixed connective tissue disease. Lupus 19(2):223\u2013224. https:\/\/doi.org\/10.1177\/0961203309345782","journal-title":"Lupus"},{"key":"3935_CR24","doi-asserted-by":"crossref","unstructured":"Rayes HA, Al-Sheikh A, Al Dalaan A, Al Saleh S (2002) Mixed connective tissue disease: the King Faisal Specialist Hospital experience. Ann Saudi Med 22(1\u20132):43\u201346","DOI":"10.5144\/0256-4947.2002.43"},{"issue":"1","key":"3935_CR25","first-page":"265","volume":"54","author":"WJ Habets","year":"1983","unstructured":"Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, van Venrooij WJ (1983) Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 54(1):265\u2013276","journal-title":"Clin Exp Immunol"},{"key":"3935_CR26","doi-asserted-by":"crossref","unstructured":"Xuan Z, Yi D, Fu-Lin T, Fen-Chun Z (1999) Central nervous system involvement in systemic lupus erythematosus in a hospital-based study of 171 cases: the possible therapeutic role of intrathecal therapy. J Clin Rheumatol 5(6):314\u2013319","DOI":"10.1097\/00124743-199912000-00003"},{"issue":"6","key":"3935_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0002-9343(78)90747-7","volume":"65","author":"RM Bennett","year":"1978","unstructured":"Bennett RM, Bong DM, Spargo BH (1978) Neuropsychiatric problems in mixed connective tissue disease. Am J Med 65(6):955\u2013962","journal-title":"Am J Med"},{"issue":"5","key":"3935_CR28","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::aid-anr8>3.0.co;2-l","volume":"42","author":"MA Burdt","year":"1999","unstructured":"Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42(5):899\u2013909. https:\/\/doi.org\/10.1002\/1529-0131(199905)42:5<899::aid-anr8>3.0.co;2-l","journal-title":"Arthritis Rheum"},{"key":"3935_CR29","doi-asserted-by":"publisher","unstructured":"Hojaili B, Barland P (2006) Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder. J Clin Rheumatol 12(3):145\u2013147. https:\/\/doi.org\/10.1097\/01.rhu.0000222045.70861.a5","DOI":"10.1097\/01.rhu.0000222045.70861.a5"},{"key":"3935_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/b978-0-7020-4086-3.00037-0","volume":"119","author":"S Debette","year":"2014","unstructured":"Debette S, Germain DP (2014) Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol 119:565\u2013576. https:\/\/doi.org\/10.1016\/b978-0-7020-4086-3.00037-0","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"3935_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0733-8619(03)00057-4","volume":"20","author":"SE Nadeau","year":"2002","unstructured":"Nadeau SE (2002) Neurologic manifestations of connective tissue disease. Neurol Clin 20(1):151\u2013178 vi","journal-title":"Neurol Clin"},{"key":"3935_CR32","doi-asserted-by":"publisher","unstructured":"Karmacharya P, Mainali N, Aryal M, Lloyd B (2013) Recurrent case of ibuprofen-induced aseptic meningitis in mixed connective tissue disease. BMJ Case Rep 2013. https:\/\/doi.org\/10.1136\/bcr-2013-009571","DOI":"10.1136\/bcr-2013-009571"},{"key":"3935_CR33","doi-asserted-by":"publisher","unstructured":"Sato T, Fujii T, Yokoyama T, Fujita Y, Imura Y, Yukawa N, Kawabata D, Nojima T, Ohmura K, Usui T, Mimori T (2010) Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 62(12):3730\u20133740. https:\/\/doi.org\/10.1002\/art.27700","DOI":"10.1002\/art.27700"},{"key":"3935_CR34","doi-asserted-by":"publisher","unstructured":"Shah P, Dhakre V, Bhabhor A, Prasad A (2018) Superior sagittal sinus thrombosis in a case of mixed connective tissue disease. BMJ Case Rep 2018. https:\/\/doi.org\/10.1136\/bcr-2018-225078","DOI":"10.1136\/bcr-2018-225078"},{"key":"3935_CR35","doi-asserted-by":"publisher","unstructured":"Kim ST, Brinjikji W, Lanzino G, Kallmes DF (2016) Neurovascular manifestations of connective-tissue diseases: a review. Interv Neuroradiol 22(6):624\u2013637. https:\/\/doi.org\/10.1177\/1591019916659262","DOI":"10.1177\/1591019916659262"},{"key":"3935_CR36","doi-asserted-by":"crossref","unstructured":"Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M (2006) Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease. Neurol India 54(1):83\u201385","DOI":"10.4103\/0028-3886.24716"},{"issue":"5","key":"3935_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/art.1780190503","volume":"19","author":"J Leibfarth","year":"1976","unstructured":"Leibfarth J, Persellin R (1976) Characteristics of patients with serum antibodies to extractable nuclear antigens. Arthritis Rheum 19(5):851\u2013856","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3935_CR38","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3899\/jrheum.081314","volume":"36","author":"A Hajas","year":"2009","unstructured":"Hajas A, Szodoray P, Barath S, Sipka S, Rezes S, Zeher M, Sziklai I, Szegedi G, Bodolay E (2009) Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels. J Rheumatol 36(9):1930\u20131936","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"3935_CR39","first-page":"S141","volume":"24","author":"I Kiani","year":"2014","unstructured":"Kiani I, Qureshi S, Shah F (2014) Depression and seizures as the main neuropsychiatric manifestation of mixed connective tissue disorder. J Coll Physicians Surg Pak 24(Suppl 2):S141\u2013S143","journal-title":"J Coll Physicians Surg Pak"},{"key":"3935_CR40","doi-asserted-by":"crossref","unstructured":"Manohar H, Kuppili P, Menon V (2017) Major depression: An under reported neuropsychiatric manifestation of mixed connective tissue disease. Asian J Psychiatr 30:54\u201355","DOI":"10.1016\/j.ajp.2017.07.011"},{"issue":"9","key":"3935_CR41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/0961203312441511","volume":"21","author":"K Nowicka-Sauer","year":"2012","unstructured":"Nowicka-Sauer K, Czuszynska Z, Majkowicz M, Smolenska Z, Jarmoszewicz K, Olesinska M, Siebert J (2012) Neuropsychological assessment in mixed connective tissue disease: comparison with systemic lupus erythematosus. Lupus 21(9):927\u2013933","journal-title":"Lupus"},{"issue":"12","key":"3935_CR42","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neurol.2010.07.037","volume":"166","author":"M Laffon-Pioger","year":"2010","unstructured":"Laffon-Pioger M, Rocher F, Cohen M, Chanalet S, Thomas P, Lebrun C (2010) Bilateral optic neuropathy with loss of vision after an influenza vaccination in a patient suffering from mixed connective tissue disease. Rev Neurol (Paris) 166(12):1024\u20131027","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"3935_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0022-510X(94)90264-X","volume":"126","author":"K Flechtner","year":"1994","unstructured":"Flechtner K, Baum K (1994) Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis. J Neurol Sci 126(2):146\u2013148","journal-title":"J Neurol Sci"},{"issue":"2","key":"3935_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF02201041","volume":"6","author":"C Pedersen","year":"1987","unstructured":"Pedersen C, Bonen H, Boesen F (1987) Transverse myelitis in mixed connective tissue disease. Clin Rheumatol 6(2):290\u2013292","journal-title":"Clin Rheumatol"},{"key":"3935_CR45","unstructured":"Obara K, Tanaka K (1991) A case of mixed connective tissue disease (MCTD) associated with transverse myelitis responding to pulse therapy. Rinsho Shinkeigaku 31(11):1197\u20131201"},{"issue":"3","key":"3935_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0303-8467(95)00045-L","volume":"97","author":"CC Mok","year":"1995","unstructured":"Mok CC, Lau CS (1995) Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 97(3):259\u2013260","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"3935_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10067-005-0158-1","volume":"26","author":"S Bhinder","year":"2007","unstructured":"Bhinder S, Harbour K, Majithia V (2007) Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease--a case report and a review of literature. Clin Rheumatol 26(3):445\u2013447. https:\/\/doi.org\/10.1007\/s10067-005-0158-1","journal-title":"Clin Rheumatol"},{"issue":"31","key":"3935_CR48","doi-asserted-by":"publisher","first-page":"e11360","DOI":"10.1097\/md.0000000000011360","volume":"97","author":"Y Hao","year":"2018","unstructured":"Hao Y, Feng L, Teng Y, Cheng Y, Feng J (2018) Management of multiple neurological complications in mixed connective tissue disease: a case report. Medicine 97(31):e11360. https:\/\/doi.org\/10.1097\/md.0000000000011360","journal-title":"Medicine"},{"issue":"4","key":"3935_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/jnnp.68.4.532","volume":"68","author":"SJ Weatherby","year":"2000","unstructured":"Weatherby SJ, Davies MB, Hawkins CP, Haq N, Dawes P (2000) Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy. J Neurol Neurosurg Psychiatry 68(4):532\u2013533","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3935_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/1756-185x.12793","volume":"20","author":"A Kucuk","year":"2017","unstructured":"Kucuk A, Uslu AU, Yilmaz R, Salbas E, Solak Y, Tunc R (2017) Relationship between prevalence and severity of restless legs syndrome and anemia in patients with systemic lupus erythematosus. Int J Rheum Dis 20(4):469\u2013473. https:\/\/doi.org\/10.1111\/1756-185x.12793","journal-title":"Int J Rheum Dis"},{"key":"3935_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1749-6632.2009.05368.x","volume":"1193","author":"J Schedel","year":"2010","unstructured":"Schedel J, Kuchenbuch S, Schoelmerich J, Feuerbach S, Geissler A, Mueller-Ladner U (2010) Cerebral lesions in patients with connective tissue diseases and systemic vasculitides: are there specific patterns? Ann N Y Acad Sci 1193:167\u2013175","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3935_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/annrheumdis-2016-209522","volume":"76","author":"S Hetlevik","year":"2017","unstructured":"Hetlevik S, Flat\u00f8 B, Rygg M, Nordal E, Brunborg C, Hetland H, Lilleby V (2017) Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis 76(1):159\u2013165","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3935_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13256-016-0955-y","volume":"10","author":"R Rahmanzadeh","year":"2016","unstructured":"Rahmanzadeh R, Rahmanzade R, Zabihiyeganeh M (2016) Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report. J Med Case Rep 10(1):145","journal-title":"J Med Case Rep"},{"issue":"2","key":"3935_CR54","first-page":"251","volume":"50","author":"A Tristano","year":"2009","unstructured":"Tristano A (2009) Autoimmune diseases associated with transverse myelitis. Review. Investig Clin 50(2):251\u2013270","journal-title":"Investig Clin"},{"issue":"12","key":"3935_CR55","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1191\/0961203303lu495oa","volume":"12","author":"O Nived","year":"2003","unstructured":"Nived O, Sturfelt G, Liang MH, De Pablo P (2003) The ACR nomenclature for CNS lupus revisited. Lupus 12(12):872\u2013876. https:\/\/doi.org\/10.1191\/0961203303lu495oa","journal-title":"Lupus"},{"issue":"2","key":"3935_CR56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.59.2.120","volume":"59","author":"B Kovacs","year":"2000","unstructured":"Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120\u2013124","journal-title":"Ann Rheum Dis"},{"key":"3935_CR57","doi-asserted-by":"crossref","unstructured":"Ahn S, Hong S, Lim D, Ghang B, Kim Y, Lee C, Yoo B (2018) Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus. Korean J Intern Med. 34(2):442-451. doi: 10.3904\/kjim.2016.383.\u00a0","DOI":"10.3904\/kjim.2016.383"},{"issue":"6","key":"3935_CR58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.reuma.2016.06.004","volume":"13","author":"E Chiganer","year":"2017","unstructured":"Chiganer E, Hryb J, Carnero Contentti E (2017) Myelitis and lupus: clinical manifestations, diagnosis and treatment. Review Reumatol Clin 13(6):344\u2013348","journal-title":"Review Reumatol Clin"},{"issue":"4","key":"3935_CR59","first-page":"e2402","volume":"10","author":"A Zahid","year":"2018","unstructured":"Zahid A, Mubashir A, Mirza S, Naqvi I, Talib A (2018) Systemic lupus erythematosus presenting as longitudinally extensive transverse myelitis and nephritis: a case report. Cureus 10(4):e2402","journal-title":"Cureus"},{"key":"3935_CR60","doi-asserted-by":"publisher","unstructured":"Saison J, Costedoat-Chalumeau N, Maucort-Boulch D, Iwaz J, Marignier R, Cacoub P, Vital-Durand D, Hot A, Tebib J, Aumaitre O, Schleinitz N, Sarrot-Reynauld F, Broussolle C, Seve P (2015) Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients. Lupus 24(1):74\u201381. https:\/\/doi.org\/10.1177\/0961203314547795","DOI":"10.1177\/0961203314547795"},{"key":"3935_CR61","unstructured":"Harel L, Sandborg C, Lee T, von Scheven E (2006) Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 33(9):1873\u20131877"},{"key":"3935_CR62","doi-asserted-by":"crossref","unstructured":"Proposed diagnostic criteria and nosology of acute transverse myelitis (2002). Neurology 59 (4):499\u2013505","DOI":"10.1212\/WNL.59.4.499"},{"issue":"8","key":"3935_CR63","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/0961203318770015","volume":"27","author":"F Flores-Silva","year":"2018","unstructured":"Flores-Silva F, Longoria-Lozano O, Aguirre-Villarreal D, Sent\u00edes-Madrid H, Vega-Boada F, D\u00edaz de Le\u00f3n-S\u00e1nchez E, Murra-Ant\u00f3n S, Morales-Moreno S, Quintanilla-Gonz\u00e1lez L, Fragoso-Loyo H, Guraieb-Cha\u00edn P, Higuera-Calleja J, Ceballos-Ceballos J, Trevi\u00f1o-Frenk I, Gonz\u00e1lez-Duarte A, D\u00e1vila-Maldonado L, Cant\u00fa-Brito C, Vald\u00e9s-Ferrer S (2018) Natural history of longitudinally extensive transverse myelitis in 35 Hispanic patients with systemic lupus erythematosus: good short-term functional outcome and paradoxical increase in long-term mortality. Lupus 27(8):1279\u20131286","journal-title":"Lupus"},{"issue":"4","key":"3935_CR64","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/096120339600500409","volume":"5","author":"K Chan","year":"1996","unstructured":"Chan K, Boey M (1996) Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 5(4):294\u2013299","journal-title":"Lupus"},{"issue":"4","key":"3935_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1191\/0961203306lu2269cr","volume":"15","author":"F Lehnhardt","year":"2006","unstructured":"Lehnhardt F, Scheid C, Holtik U, Burghaus L, Neveling M, Impekoven P, R\u00fcger A, Hallek M, Jacobs A, Rubbert A (2006) Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 15(4):240\u2013243","journal-title":"Lupus"},{"issue":"3","key":"3935_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10067-002-8287-2","volume":"21","author":"Y Sherer","year":"2002","unstructured":"Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies--the importance of early diagnosis and treatment. Clin Rheumatol 21(3):207\u2013210","journal-title":"Clin Rheumatol"},{"key":"3935_CR67","doi-asserted-by":"crossref","unstructured":"Soltesz P, Bereczki D, Szodoray P, Magyar M, Der H, Csipo I, Hajas A, Paragh G, Szegedi G, Bodolay E (2010) Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther 12(3):R78","DOI":"10.1186\/ar2999"},{"issue":"4","key":"3935_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5114\/reum.2016.62473","volume":"54","author":"E Ha\u0142adyj","year":"2016","unstructured":"Ha\u0142adyj E, Paradowska-Gorycka A, Felis-Giemza A, Olesi\u0144ska M (2016) Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome. Reumatologia 54(4):187\u2013195","journal-title":"Reumatologia"},{"issue":"6","key":"3935_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.autrev.2010.11.006","volume":"10","author":"A Hajas","year":"2011","unstructured":"Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, Seres I, Szegedi G, Shoenfeld Y, Bodolay E (2011) Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 10(6):317\u2013324","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3935_CR70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/03009740802007514","volume":"37","author":"E Svenungsson","year":"2008","unstructured":"Svenungsson E, Cederholm A, Jensen-Urstad K, Fei G, de Faire U, Frosteg\u00e5rd J (2008) Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus. Scand J Rheumatol 37(5):352\u2013359","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"3935_CR71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1006\/jaut.1998.0236","volume":"11","author":"A Bakri Hassan","year":"1998","unstructured":"Bakri Hassan A, R\u00f6nnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I (1998) Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. J Autoimmun 11(5):503\u2013508","journal-title":"J Autoimmun"},{"issue":"1","key":"3935_CR72","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12026-014-8552-x","volume":"60","author":"E Bodolay","year":"2014","unstructured":"Bodolay E, Proh\u00e1szka Z, Paragh G, Csip\u0151 I, Nagy G, Laczik R, Demeter N, Z\u00f6ld E, Nakken B, Szegedi G, Szodoray P (2014) Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease. Immunol Res 60(1):50\u201359","journal-title":"Immunol Res"},{"issue":"2","key":"3935_CR73","first-page":"251","volume":"50","author":"AG Tristano","year":"2009","unstructured":"Tristano AG (2009) Autoimmune diseases associated with transverse myelitis. Rev Investig Clin 50(2):251\u2013270","journal-title":"Rev Investig Clin"},{"issue":"1","key":"3935_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13760-012-0006-4","volume":"112","author":"M Habek","year":"2012","unstructured":"Habek M, Adamec I, Pavli\u0161a G, Brinar V (2012) Diagnostic approach of patients with longitudinally extensive transverse myelitis. Acta Neurol Belg 112(1):39\u201343","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"3935_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0972-2327.199904","volume":"20","author":"A Kayal","year":"2017","unstructured":"Kayal A, Goswami M, Das M, Basumatary L, Bhowmick S, Synmon B (2017) Etiological profile of noncompressive myelopathies in a tertiary care hospital of Northeast India. Ann Indian Acad Neurol 20(1):41\u201350","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"3935_CR76","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s10072-018-3491-2","volume":"39","author":"F Wang","year":"2018","unstructured":"Wang F, Guo D, Liu Z, Zhou A, Wei C, Jia J (2018) Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients. Neurol Sci 39(10):1725\u20131733. https:\/\/doi.org\/10.1007\/s10072-018-3491-2","journal-title":"Neurol Sci"},{"issue":"8","key":"3935_CR77","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/archneur.63.8.1113","volume":"63","author":"J Novy","year":"2006","unstructured":"Novy J, Carruzzo A, Maeder P, Bogousslavsky J (2006) Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 63(8):1113\u20131120","journal-title":"Arch Neurol"},{"issue":"10","key":"3935_CR78","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/jnnp.2003.031724","volume":"75","author":"C Masson","year":"2004","unstructured":"Masson C, Pruvo J, Meder J, Cordonnier C, Touz\u00e9 E, De La Sayette V, Giroud M, Mas J, Leys D (2004) Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 75(10):1431\u20131435","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3935_CR79","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","volume":"54","author":"A Vaknin-Dembinsky","year":"2014","unstructured":"Vaknin-Dembinsky A, Karussis D, Avichzer J, Abramsky O (2014) NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases. J Autoimmun 54:93\u201399","journal-title":"J Autoimmun"},{"issue":"3","key":"3935_CR80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/jnnp-2016-314738","volume":"88","author":"Z NL","year":"2017","unstructured":"NL Z, PP M, BG W, CF L, Y G SJP, KN K, TJ K, DM W, N K EPF (2017) Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry 88(3):218\u2013225","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3935_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/NRL.0b013e318247bc91","volume":"18","author":"K Ogaki","year":"2012","unstructured":"Ogaki K, Hirayama T, Chijiiwa K, Fukae J, Furuya T, Noda K, Fujishima K, Hattori N, Takahashi T, Okuma Y (2012) Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Neurologist 18(2):76\u201379","journal-title":"Neurologist"},{"issue":"22","key":"3935_CR82","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","volume":"376","author":"L Metz","year":"2017","unstructured":"Metz L, Li D, Traboulsee A, Duquette P, Eliasziw M, Cerchiaro G, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman M, Bhan V, Blevins G, Marriott J, Grand'Maison F, Lee L, Thibault M, Hill M, Yong V (2017) Trial of minocycline in a clinically isolated syndrome of multiple sclerosis. N Engl J Med 376(22):2122\u20132133","journal-title":"N Engl J Med"},{"key":"3935_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.msard.2017.09.007","volume":"18","author":"A Dehghani","year":"2017","unstructured":"Dehghani A, Nayeri N, Ebadi A (2017) Development and validation of the coping with multiple sclerosis questionnaire. Mult Scler Relat Disord 18:49\u201355","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"3935_CR84","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/WCO.0000000000000319","volume":"29","author":"P Axisa","year":"2016","unstructured":"Axisa P, Hafler D (2016) Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 29(3):345\u2013353","journal-title":"Curr Opin Neurol"},{"key":"3935_CR85","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nicl.2018.05.034","volume":"20","author":"H Kitzler","year":"2018","unstructured":"Kitzler H, Wahl H, Eisele J, Kuhn M, Schmitz-Peiffer H, Kern S, Rutt B, Deoni S, Ziemssen T, Linn J (2018) Multi-component relaxation in clinically isolated syndrome: lesion myelination may predict multiple sclerosis conversion. Neuroimage Clin 20:61\u201370","journal-title":"Neuroimage Clin"},{"issue":"8","key":"3935_CR86","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","volume":"84","author":"A Jacob","year":"2013","unstructured":"Jacob A, McKeon A, Nakashima I, Sato D, Elsone L, Fujihara K, de Seze J (2013) Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 84(8):922\u2013930","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"3935_CR87","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10072-018-3302-9","volume":"39","author":"C Zhou","year":"2018","unstructured":"Zhou C, He Y, Gao X, Zhu Y, Chao Z, Wang X (2018) Neuromyelitis optical spectrum disorders presenting with isolated \u201cinverted V\u201d sign in area postrema. Neurol Sci 39(7):1299\u20131301. https:\/\/doi.org\/10.1007\/s10072-018-3302-9","journal-title":"Neurol Sci"},{"issue":"1","key":"3935_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","volume":"72","author":"F EP","year":"2015","unstructured":"EP F, BG W, KN K, VA L, CF L, A M DMW, EA S, Y J ESH, SJ P (2015) Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA neurology 72(1):81\u201387","journal-title":"JAMA neurology"},{"issue":"2","key":"3935_CR89","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10072-016-2751-2","volume":"38","author":"YH Zhong","year":"2017","unstructured":"Zhong YH, Zhong ZG, Zhou Z, Ma ZY, Qiu MY, Peng FH, Zhang WX (2017) Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjogren's syndrome. Neurol Sci 38(2):271\u2013277. https:\/\/doi.org\/10.1007\/s10072-016-2751-2","journal-title":"Neurol Sci"},{"issue":"11","key":"3935_CR90","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/0961203310368968","volume":"19","author":"D Squatrito","year":"2010","unstructured":"Squatrito D, Colagrande S, Emmi L (2010) Devic's syndrome and primary APS: a new immunological overlap. Lupus 19(11):1337\u20131339","journal-title":"Lupus"},{"issue":"3","key":"3935_CR91","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/1352458507084107","volume":"14","author":"L Mehta","year":"2008","unstructured":"Mehta L, Samuelsson M, Kleiner A, Goodman A, Anolik J, Looney R, Schwid S (2008) Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler 14(3):425\u2013427","journal-title":"Mult Scler"},{"issue":"6","key":"3935_CR92","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archneur.63.6.851","volume":"63","author":"I Kister","year":"2006","unstructured":"Kister I, Gulati S, Boz C, Bergamaschi R, Piccolo G, Piccolo G, Oger J, Swerdlow M (2006) Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63(6):851\u2013856","journal-title":"Arch Neurol"},{"issue":"4","key":"3935_CR93","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/08830738060210040701","volume":"21","author":"B Arabshahi","year":"2006","unstructured":"Arabshahi B (2006) Devic disease in a child with primary Sjogren syndrome. J Child Neurol 21(4):284\u2013286","journal-title":"J Child Neurol"},{"key":"3935_CR94","doi-asserted-by":"crossref","unstructured":"RN S (2018) Metabolic and toxic myelopathies. Continuum (Minneapolis, Minn) 24(2):427\u2013440","DOI":"10.1212\/CON.0000000000000596"},{"issue":"2","key":"3935_CR95","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s002340050027","volume":"42","author":"K AH","year":"2000","unstructured":"AH K, A M GB (2000) Subacute combined degeneration of the spinal cord with involvement of the anterior columns: a new MRI finding. Neuroradiology 42(2):115\u2013117","journal-title":"Neuroradiology"},{"issue":"2","key":"3935_CR96","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00234-005-0016-5","volume":"48","author":"JEA N K","year":"2006","unstructured":"N K JEA, CJ K, JD P (2006) Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology 48(2):78\u201383","journal-title":"Neuroradiology"},{"issue":"8","key":"3935_CR97","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00296-005-0068-1","volume":"26","author":"D Armstrong","year":"2006","unstructured":"Armstrong D, McCarron M, Wright G (2006) SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody). Rheumatol Int 26(8):771\u2013772","journal-title":"Rheumatol Int"},{"issue":"3","key":"3935_CR98","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00002060-199306000-00010","volume":"72","author":"MD Klaiman","year":"1993","unstructured":"Klaiman MD, Miller SD (1993) Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report. Am J Phys Med Rehabil 72(3):158\u2013161","journal-title":"Am J Phys Med Rehabil"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-019-03935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T02:02:35Z","timestamp":1659060155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-019-03935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03935-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"6 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}